Stock Research for VICL

VICL

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

VICL Stock Chart & Research Data

The VICL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the VICL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


VICL Due diligence Resources & Stock Charts

The VICL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View VICL Detailed Price Forecast - CNN Money CNN View VICL Detailed Summary - Google Finance
Yahoo View VICL Detailed Summary - Yahoo! Finance Zacks View VICL Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View VICL Trends & Analysis - Trade-Ideas Barrons View VICL Major Holders - Barrons
NASDAQ View VICL Call Transcripts - NASDAQ Seeking View VICL Breaking News & Analysis - Seeking Alpha
Spotlight View VICL Annual Report - CompanySpotlight.com OTC Report View VICL OTC Short Report - OTCShortReport.com
TradeKing View VICL Fundamentals - TradeKing Charts View VICL SEC Filings - Bar Chart
WSJ View Historical Prices for VICL - The WSJ Morningstar View Performance/Total Return for VICL - Morningstar
MarketWatch View the Analyst Estimates for VICL - MarketWatch CNBC View the Earnings History for VICL - CNBC
StockMarketWatch View the VICL Earnings - StockMarketWatch MacroAxis View VICL Buy or Sell Recommendations - MacroAxis
Bullish View the VICL Bullish Patterns - American Bulls Short Pains View VICL Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View VICL Stock Mentions - StockTwits PennyStocks View VICL Stock Mentions - PennyStockTweets
Twitter View VICL Stock Mentions - Twitter Invest Hub View VICL Investment Forum News - Investor Hub
Yahoo View VICL Stock Mentions - Yahoo! Message Board Seeking Alpha View VICL Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for VICL - SECform4.com Insider Cow View Insider Transactions for VICL - Insider Cow
CNBC View VICL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for VICL - OTC Markets
Yahoo View Insider Transactions for VICL - Yahoo! Finance NASDAQ View Institutional Holdings for VICL - NASDAQ


Stock Charts

FinViz View VICL Stock Insight & Charts - FinViz.com StockCharts View VICL Investment Charts - StockCharts.com
BarChart View VICL Stock Overview & Charts - BarChart Trading View View VICL User Generated Charts - Trading View




Latest Financial News for VICL


What Investors Should Know About Vical Incorporated’s (NASDAQ:VICL) Financial Strength
Posted on Wednesday December 12, 2018

The direct benefit for Vical Incorporated (NASDAQ:VICL), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. However, the trade-off is Read More...


New Research: Key Drivers of Growth for Interface, USA Truck, Weingarten Realty Investors, Unum Group, Trivago N.V. ADS, and Vical — Factors of Influence, Major Initiatives and Sustained Production
Posted on Thursday November 01, 2018

NEW YORK, Nov. 01, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.


Vical (VICL) Reports Q3 Loss, Misses Revenue Estimates
Posted on Monday October 29, 2018

Vical (VICL) delivered earnings and revenue surprises of 36.36% and -73.14%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?


Vical: 3Q Earnings Snapshot
Posted on Monday October 29, 2018

On a per-share basis, the San Diego-based company said it had a loss of 7 cents. Losses, adjusted for non-recurring gains, were 14 cents per share. The drug developer posted revenue of $47,000 in the period. ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.